Page 2 - Pipeline Overview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pipeline overview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pipeline Overview Today - Breaking & Trending Today

15 Sales Forecasting Software Options for Small Businesses

Here is a comprehensive list of the 15 best sales forecasting software, offering a range of features and pricing plans for your business. ....

Monitoring Sales Team Performance , Sales Forecasting Software , Hubspot Forecasting Software , Team Collaboration , Sales Forecasting Software Options , Future Sales Volumes , Market Trends , Historical Data , Multiple Factors , Strategic Decisions , Sales Targets , Sales Forecasting , Best Sales Forecasting Software , Maximized Productivity , Pipeline Visibility , Powered Sales Tool , Sells Faster , Sales Pipeline , Win Deals , Automate Data , Drives Revenue , Performance Management , Agile Sales Strategies , Self Service Access , Financial Planning , Automatic Interpretation ,

Axsome Therapeutics (NASDAQ:AXSM) Sets New 52-Week High at $84.61

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $84.61 and last traded at $84.13, with a volume of 396981 shares trading hands. The stock had previously closed at $80.91. Wall Street Analyst Weigh In AXSM has been the topic of […] ....

Vanguard Group Inc , Axsome Therapeutics Company Profile , Morgan Stanley , Axsome Therapeutics Inc , Health Sciences , Axsome Therapeutics , Get Rating , Products Overview , Pipeline Overview , Axsome Therapeutics Daily ,

Endurant Capital Management LP Buys Shares of 11,264 Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Endurant Capital Management LP bought a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 11,264 shares of the company’s stock, valued at approximately $869,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] ....

United States , Axsome Therapeutics Inc , Health Sciences , Cannell Co , Morgan Stanley , Tower Research Capital , Legato Capital Management , Holdings Channel , Endurant Capital Management , Axsome Therapeutics , Get Rating , Capital Management , Research Capital , Products Overview , Pipeline Overview , Visit Holdingschannel , Axsome Therapeutics Daily , Nasdaq Axsm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Driehaus Capital Management LLC Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Driehaus Capital Management LLC bought a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 233,095 shares of the company’s stock, valued at approximately $17,979,000. A number of other institutional investors and hedge funds also recently made changes to their positions in the […] ....

United States , Driehaus Capital Management , Axsome Therapeutics Inc , Armstrong Advisory Group Inc , Morgan Stanley , Holdings Channel , Quent Capital , Axsome Therapeutics , Get Rating , Financial Advisors , Advisory Group , Quantbot Technologies , Products Overview , Pipeline Overview , Visit Holdingschannel , Axsome Therapeutics Daily ,

Brokerages Set Axsome Therapeutics, Inc. (NASDAQ:AXSM) PT at $105.57

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. […] ....

United States , China Universal Asset Management Co , Armstrong Advisory Group Inc , Axsome Therapeutics Inc , Axsome Therapeutics Company Profile , Morgan Stanley , Tower Research Capital , Axsome Therapeutics , Get Rating , Advisory Group , Universal Asset Management , Financial Advisors , Research Capital , Products Overview , Pipeline Overview , Axsome Therapeutics Daily , Nasdaq Axsm ,